Total Payments
$10,807
2024 Payments
$2,663
Companies
58
Transactions
577
Medicare Patients
4,802
Medicare Billing
$469,772
Payment Breakdown by Category
Food & Beverage$10,801 (99.9%)
Education$6.02 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,801 | 576 | 99.9% |
| Education | $6.02 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,877 | 103 | $0 (2024) |
| PFIZER INC. | $1,096 | 83 | $0 (2024) |
| ABBVIE INC. | $963.39 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $877.58 | 50 | $0 (2024) |
| Lilly USA, LLC | $602.19 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $601.26 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $521.44 | 26 | $0 (2024) |
| Amgen Inc. | $401.33 | 27 | $0 (2023) |
| GlaxoSmithKline, LLC. | $380.06 | 19 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $328.45 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,663 | 119 | ABBVIE INC. ($465.25) |
| 2023 | $2,057 | 109 | ABBVIE INC. ($359.39) |
| 2022 | $1,813 | 89 | Novo Nordisk Inc ($368.29) |
| 2021 | $716.71 | 39 | Novo Nordisk Inc ($296.81) |
| 2020 | $906.04 | 56 | Novo Nordisk Inc ($260.59) |
| 2019 | $1,192 | 81 | Novo Nordisk Inc ($282.47) |
| 2018 | $685.38 | 40 | PFIZER INC. ($128.53) |
| 2017 | $774.27 | 44 | SANOFI-AVENTIS U.S. LLC ($157.14) |
All Payment Transactions
577 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Vaccines | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.52 | General |
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: PAIN | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/21/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $90.00 | General |
| Category: Obesity | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.06 | General |
| Category: PAIN | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Obesity | ||||||
| 11/06/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: PAIN | ||||||
| 11/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: PAIN | ||||||
| 10/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $104.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,251 | 1,589 | $285,280 | $137,959 |
| 2022 | 13 | 1,213 | 1,540 | $267,119 | $127,345 |
| 2021 | 15 | 1,162 | 1,468 | $240,081 | $109,191 |
| 2020 | 14 | 1,176 | 1,511 | $233,785 | $95,276 |
Total Patients
4,802
Total Services
6,108
Medicare Billing
$469,772
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 287 | 510 | $117,540 | $46,708 | 39.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 242 | 242 | $60,500 | $32,276 | 53.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 78 | 78 | $27,144 | $21,998 | 81.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 190 | 250 | $39,933 | $15,257 | 38.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 78 | 78 | $7,020 | $5,594 | 79.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 23 | $10,120 | $3,709 | 36.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $4,000 | $2,737 | 68.4% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 21 | 21 | $3,885 | $2,698 | 69.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 84 | 85 | $3,071 | $2,684 | 87.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 73 | 74 | $2,146 | $2,103 | 98.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 21 | 21 | $1,995 | $897.33 | 45.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 43 | 44 | $3,300 | $495.69 | 15.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 46 | $3,312 | $439.47 | 13.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 43 | 51 | $805.33 | $254.00 | 31.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 42 | 50 | $509.50 | $110.00 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 312 | 570 | $131,220 | $53,790 | 41.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 219 | 219 | $54,750 | $29,994 | 54.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 169 | 208 | $33,280 | $13,364 | 40.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 42 | 42 | $14,616 | $11,698 | 80.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 95 | 95 | $8,410 | $6,488 | 77.2% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 23 | 24 | $10,560 | $4,158 | 39.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 98 | 98 | $3,136 | $3,049 | 97.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $2,880 | $1,598 | 55.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 51 | 51 | $1,479 | $1,458 | 98.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 13 | 13 | $1,599 | $658.81 | 41.2% |
About Dr. Jerry Myrda, DO
Dr. Jerry Myrda, DO is a Internal Medicine healthcare provider based in Elgin, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1578564753.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerry Myrda, DO has received a total of $10,807 in payments from pharmaceutical and medical device companies, with $2,663 received in 2024. These payments were reported across 577 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($10,801).
As a Medicare-enrolled provider, Myrda has provided services to 4,802 Medicare beneficiaries, totaling 6,108 services with total Medicare billing of $469,772. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Elgin, IL
- Active Since 08/10/2005
- Last Updated 12/29/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1578564753
Products in Payments
- Ozempic (Drug) $937.73
- VRAYLAR (Drug) $669.67
- JARDIANCE (Drug) $553.14
- NURTEC ODT (Drug) $486.30
- Wegovy (Drug) $366.99
- SPRAVATO (Drug) $345.73
- CHANTIX (Drug) $335.95
- VOQUEZNA (Drug) $328.45
- FARXIGA (Drug) $319.41
- XARELTO (Drug) $249.51
- TRELEGY ELLIPTA (Drug) $241.39
- EMGALITY (Drug) $236.23
- REXULTI (Drug) $223.37
- Rybelsus (Drug) $199.56
- EVENITY (Biological) $198.84
- Qutenza (Drug) $178.93
- UBRELVY (Drug) $171.14
- SYMBICORT (Drug) $161.68
- TOUJEO (Drug) $161.49
- ELIQUIS (Drug) $151.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elgin
Mr. Michael Hernandez, M.d, M.D
Internal Medicine — Payments: $26,674
Internal Medicine $26,674
Dr. Robert Tiballi, D.o, D.O
Internal Medicine — Payments: $20,485
Internal Medicine $20,485
Paula Belmar, Md, MD
Internal Medicine — Payments: $12,301
Internal Medicine $12,301
Dr. Heena Shyamani, M.d, M.D
Internal Medicine — Payments: $12,014
Internal Medicine $12,014
Mr. Richard Baley, M.d, M.D
Internal Medicine — Payments: $11,178
Internal Medicine $11,178
John Adams, Md, MD
Internal Medicine — Payments: $10,883
Internal Medicine $10,883